Presenilins: a group of novel calcium channel modulators.

Slides:



Advertisements
Similar presentations
Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? Lockhart BP, Lestage PJ. January 2003.
Advertisements

Cell Communication Cells need to communicate with one another, whether they are located close to each other or far apart. Extracellular signaling molecules.
Cell Signaling A. Types of Cell Signaling
DRUG-RECEPTOR INTERACTIONS
Calcium-Activated Potassium Channels: Multiple Contributions to Neuronal Function E.S. Louise Faber and Pankaj Sah PPT by Anvinh Nguyen.
This is only for personal educational purposes.
ALZHEIMER’S DISEASE Erin Dancey. Overview Alzheimer’s is the most common cause of dementia in adult life and is associated with the selective damage of.
ALZHEIMER'S DISEASE (AD)
Neurodex TM Palliates Pseudobulbar Affect: An Overview of the Pathogenesis of Pseudobulbar Affect and the Pharmacologic Mechanism of Action of Neurodex.
Abby Suelflow 9 April  Distributed in many regions of adult brain  Multiple BDNF transcripts that encode exact same protein  BDNF promotors involved.
Mind, Brain & Behavior Monday January 27, Connections Among Neurons  The growing tip of an axon is called a growth cone.  Lamellipodia – flaps.
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
INTRODUCTION Mutations in Presenilin (PS) 1 and 2 cause familial Alzheimer’s Disease (AD) through undetermined mechanisms. PS’s are intramembranous aspartyl.
Copyright © 2007 Wolters Kluwer Health | Lippincott Williams & Wilkins Neuroscience: Exploring the Brain, 3e Chapter 25: Molecular Mechanisms of Learning.
AMPAKINE Compounds for the Treatment of Rett Syndrome
Nature may have the answers for Alzheimer’s disease Sungkwon Chung Dept. of Physiology Sungkyunkwan University School of Medicine.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Molecular mechanisms of memory. How does the brain achieve Hebbian plasticity? How is the co-activity of presynaptic and postsynaptic cells registered.
2005 All Hands Meeting Science of the Mouse models of human neurodegenerative disease.
Molecular mechanism for Alzheimer’s disease : searching for the possible therapeutic targets Sungkwon Chung Dept. of Physiology Sungkyunkwan Univ. School.
Trafficking and processing of APP  and  -secretase.
Cell to Cell Communication
CLINICAL AND RESEARCH MEMORY CENTER LARIBOISIERE HOSPITAL PARIS FRANCE UNIVERSITY OF PARIS DIDEROT INSERM UNIT 942 INVOLVEMENT OF PKR IN ALZHEIMER’S DISEASE.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Genetic enhancement of learning and memory in mice. Tang YP et al.
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
Alzheimer’s Disease and the influence of Presenilin 1
The Synapse and Synaptic Transmission
Camara M1, Anscomb H.L. 2 and Baune B.T. 1,2
B rain D erived N eurotrophic F actor.
Contributions of BDNF to the Maturation of Cortical Inhibitory Circuits Ali Hamodi.
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Human Physiology Organ Systems
Metabotropic Neurotransmitter Receptors
Ying Cheng (1st-year PhD), supervised by Dr Gayle Doherty
Alzheimer’s Disease.
Sustaining Proliferative Signaling and Evading Growth Suppressors
Figure Adenylyl cyclase Phosphodiesterase Pyrophosphate AMP
Neuroscience Fundamentals 112C Ian Parker
Basics of Signal Transduction
Nat. Rev. Cardiol. doi: /nrcardio
Cancer and Cell Communication
Molecular Biology and Medicine
Gene expression, LTP, ion channels, enzymes, cell death
Chapter 11 Cell-to-cell communication is essential for multicellular organisms Biologists have discovered some universal mechanisms of cellular regulation.
Acetylation Unleashes Protein Demons of Dementia
THE NEW MEDICINE AND BIOLOGY Will they be Information Sciences?
ION CHANNELS AS DRUG TARGETS &
Probing the Biology of Alzheimer's Disease in Mice
Volume 69, Issue 10, Pages (May 2006)
Causes of Schizophrenia:
The Autistic Neuron: Troubled Translation?
Unit III Information Essential to Life Processes
AH Biology: cells and proteins- PPT 6
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease  Christian Lüscher, Kimberly M. Huber  Neuron 
Volume 90, Issue 2, Pages (April 2016)
Alzheimer’s Disease and the influence of Presenilin 1
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease  Christian Lüscher, Kimberly M. Huber  Neuron 
Neurotransmitters.
MicroRNA Control in the Immune System: Basic Principles
Alzheimer’s Disease Neurobiology
Alzheimer Mechanisms and Therapeutic Strategies
Cerebellar ataxias: Insights from recent preclinical and clinical studies Simon Kaja, Ph.D. Assistant Professor, Associate Director Preclinical Research.
CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease  Fang Huang, Minghui Wang, Rong Liu, Jian-Zhi Wang, Eric Schadt, Vahram.
Cell Signal Transduction and Diseases
Linking Calcium to Aβ and Alzheimer's Disease
Neuroscience: Exploring the Brain, 3e
Neurons: Cellular and Network Properties
Presentation transcript:

Presenilins: a group of novel calcium channel modulators. Simon Kaja, Ph.D. Assistant Professor, Associate Director Preclinical Research University of Missouri – Kansas City, School of Medicine Dept. of Ophthalmology, Vision Research Center Chief Executive Officer and Co-Founder K&P Scientific LLC Kansas City, MO Director North American Operations Experimentica Ltd. Kuopio, Finalnd

Ca2+ signaling 1/3 of the genome are regulated by Ca2+ Calcium-mediated processes: - Gene transcription Cell growth and differentiation Apoptosis Synaptic plasticity Secretion Neurotransmitter release Cell motility & contraction Enzyme activity [Ca2+] elevating pathways Voltage-gated Ca2+ channels Intracellular Ca2+ channels [Ca2+] buffering pathways

Calcium signaling in disease Mutations in accessory proteins: Cerebellar ataxia Alzheimer’s disease Autism Movement disorders Hypercalcemia … Age-related changes in Ca2+ signaling: Healthy aging Glaucoma Dementia Parkinson’s Disease Dry-eye disease Mutations in calcium channels: Migraine Ataxia Epilepsy Polycystic kidney disease Hypothermia Night-blindness Cardiac arrhythmia Turner’s syndrome …

Pathological cleavage of APP in AD

Presenilin proteins Structure and function: Component of the γ-secretase aspartyl protease component of the γ-secretase complex Two proteins: PS1 and PS2 PS mutations linked to familial AD PS1 and PS2 mutations increase γ-secretase activity 9 TM SR/ER proteins Rationale: PS mutations increase [RyR]

Presenilin homology Payne et al., 2013

PS1 NTF increases open probability of the brain RyR Rybalchenko et al., 2008; and Hayrapetyan et al, 2008

PS2 NTF increases open probability of the brain RyR Rybalchenko et al., 2008; and Hayrapetyan et al, 2008

PS NTFs differentially modulate intracellular Ca2+ release Functional Ca2+ imaging in SH-SY5Y neuroblastoma cells overexpressing PS1 or PS2 Payne et al., 2013

PS NTFs differentially modulate intracellular Ca2+ release Payne et al., 2013

PS NTFs differentially modulate intracellular Ca2+ release Payne et al., 2013

PS NTFs differentially modulate intracellular Ca2+ release Payne et al., 2013

Model of PS modulation of the RyR Ca2+ binds the high affinity stimulatory site resulting in moderate channel opening. Sustained Ca2+ release will result in Ca2+ occupying the low affinity, inhibitory Ca2+ binding site resulting in channel closure. Payne et al., 2013

PS1NTF increases channel opening, causing rapid Ca2+ release. The increased rate of Ca2+ release results in an overall reduced Ca2+ release as inhibitory concentrations are reached faster. Payne et al., 2013

Proposed mechanism PS2NTF has no effect on channel gating but blocks Ca2+ inhibition of the RyR channel at high cytosolic Ca2+ concentrations. Significantly elevated cytosolic Ca2+ concentrations lead to eventual binding of Ca2+ at the low affinity inhibitory site, closing the channel and resulting in an overall higher cytosolic Ca2+ concentration. Payne et al., 2013

Presenilins in “healthy” aging Aged wild-type C57/B6 mice 6 months vs. 24 months Advantages: Established non-genetic, inbred model Closely mimics human condition Many transgenic strains are based on B6 background Mild phenotypes compared with genetic models Experimental approach: Behavioral characterization Quantification of Ca2+ signaling pathways Correlation between Ca2+ signaling molecules and behavioral phenotypes

Behavioral paradigms Water maze test Bridge walking test Assess spatial learning and memory Areas involved: cortical Measures: speed, latency, pathlength Learning Index Assesses motor function and fine tuning Areas involved: cerebellum Measures: Latency to Fall (LTF); time limit: 60 sec Latency to Fall (LTF)

Impaired spatial learning & memory with age Kaja et al., 2013; Kaja et al., in press

Impaired motor function with age Kaja et al., 2013; Kaja et al., in press

Increased in PS2 in aged cerebellum Kaja et al., in press

Increased PS levels in aged forebrain Kaja et al., in press

Proposed mechanism Kaja et al., in press

Conclusions Presenilins are potent modulators of intracellular RyR calcium channels The N-terminal fragment of PS increases RyR-mediated calcium release through a direct mechanism The ratio of PS1 to PS2 is decreased in the aging brain Increased PS2 levels correlate with motor function deficits and cognitive decline PS2 likely contributes to AD pathogenesis when increased cytosolic calcium concentrations are present. Our data supports a role of PS proteins as part of both the calcium hypothesis and the Aβ hypothesis of AD. PS proteins represent novel drug targets for neuroprotection and modulation of the intracellular calcium concentration. 9/18/2018

UMKC School of Medicine Vision Research Center Acknowledgements UMKC School of Medicine Vision Research Center Peter Koulen, Ph.D. Andrew Payne, Ph.D. Bryan Gerdes, B.S. Yuliya Naumchuk, B.S. Students: Imran Puthawala Vidhi V. Shah Alexandra N. Maynard Audrey E. McCalley Collaborators University of Missouri – Kansas City Nilofer Qureshi, Ph.D. Asaf Qureshi, Ph.D. Charles Van Way III, M.D. Ann Smith, Ph.D. University of North Texas Michael Forster, Ph.D. Nathalie Sumien, Ph.D. 9/18/2018